- Home
- SUPN vs GSHD Comparison
SUPN vs GSHD Comparison
Compare SUPN & GSHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- GSHD
- Stock Information
- Founded
- SUPN 2005
- GSHD 2003
- Country
- SUPN United States
- GSHD United States
- Employees
- SUPN N/A
- GSHD N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- GSHD Specialty Insurers
- Sector
- SUPN Health Care
- GSHD Finance
- Exchange
- SUPN Nasdaq
- GSHD Nasdaq
- Market Cap
- SUPN 2.6B
- GSHD 2.2B
- IPO Year
- SUPN 2012
- GSHD 2018
- Fundamental
- Price
- SUPN $47.92
- GSHD $67.14
- Analyst Decision
- SUPN Buy
- GSHD Hold
- Analyst Count
- SUPN 2
- GSHD 10
- Target Price
- SUPN $51.50
- GSHD $106.00
- AVG Volume (30 Days)
- SUPN 682.2K
- GSHD 365.7K
- Earning Date
- SUPN 11-03-2025
- GSHD 10-22-2025
- Dividend Yield
- SUPN N/A
- GSHD 8.71%
- EPS Growth
- SUPN 1411.53
- GSHD 81.48
- EPS
- SUPN 1.14
- GSHD 1.14
- Revenue
- SUPN $665,125,000.00
- GSHD $340,762,000.00
- Revenue This Year
- SUPN $6.71
- GSHD $17.71
- Revenue Next Year
- SUPN $19.74
- GSHD $23.41
- P/E Ratio
- SUPN $42.23
- GSHD $59.42
- Revenue Growth
- SUPN 5.55
- GSHD 23.70
- 52 Week Low
- SUPN $29.16
- GSHD $66.08
- 52 Week High
- SUPN $49.66
- GSHD $130.39
- Technical
- Relative Strength Index (RSI)
- SUPN 66.02
- GSHD 24.95
- Support Level
- SUPN $47.34
- GSHD $66.08
- Resistance Level
- SUPN $49.66
- GSHD $73.43
- Average True Range (ATR)
- SUPN 1.23
- GSHD 2.67
- MACD
- SUPN -0.08
- GSHD -0.65
- Stochastic Oscillator
- SUPN 66.70
- GSHD 8.28
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About GSHD Goosehead Insurance Inc.
Goosehead Insurance Inc operates as an insurance agency. Its insurance products consist of homeowner's insurance; auto insurance; other personal lines products including flood, wind and earthquake insurance; excess liability or umbrella insurance; specialty lines insurance (motorcycle, recreational vehicle and other insurance); commercial lines insurance (general liability, property, and auto insurance for small businesses); and life insurance. Geographically, it operates in Texas, California, Illinois, Florida, and other regions.